[http://dx.doi.org/10.2174/1566523220666200607185903] [PMID: 32515310]
[http://dx.doi.org/10.2174/1566523220666200615151805] [PMID: 32538727]
[http://dx.doi.org/10.2174/1566523220999200726225457]
[http://dx.doi.org/10.2174/1566523220999200716111502] [PMID: 32674730]
[http://dx.doi.org/10.2174/1566523220999200817164051] [PMID: 32811394]
[http://dx.doi.org/10.2174/1566523220999200731011702] [PMID: 32787759]
Current Gene Therapy
Title:Gene Therapy for Neuroprotection and Neurorestoration (Part II)
Volume: 20 Issue: 3
Author(s): Ghulam Md. Ashraf and Md. Sahab Uddin
Affiliation:
Export Options
About this article
Cite this article as:
Ashraf Md. Ghulam and Uddin Sahab Md. , Gene Therapy for Neuroprotection and Neurorestoration (Part II), Current Gene Therapy 2020; 20 (3) . https://dx.doi.org/10.2174/156652322003200901112821
DOI https://dx.doi.org/10.2174/156652322003200901112821 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Triglyceride Level Affecting Shared Susceptibility Genes in Metabolic Syndrome and Coronary Artery Disease
Current Medicinal Chemistry Conference Report: (Annual Advances in Neurorestoratology: A Summary of IANR VI and 10th GCNN Conference, Bucharest, Romania, April 4-7, 2013)
CNS & Neurological Disorders - Drug Targets Short-term RR-Interval Power Spectral Analysis as a New Tool to Stratify the Risk of Sudden Death in Various Cardiovascular Conditions
Vascular Disease Prevention (Discontinued) Recent Advances on Ankle Rehabilitation Device
Recent Patents on Engineering Novel Imaging Techniques in Acute Kidney Injury
Current Drug Targets The Effect of Treatments for Rheumatoid Arthritis on Endothelial Dysfunction Evaluated by Flow-Mediated Vasodilation in Patients with Rheumatoid Arthritis
Current Vascular Pharmacology Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function?
Current Drug Targets BHUx: A Patented Polyherbal Formulation to Prevent Hyperlipidemia and Atherosclerosis
Recent Patents on Inflammation & Allergy Drug Discovery Role of Secretory Phospholipase A2 in CNS Inflammation: Implications in Traumatic Spinal Cord Injury
CNS & Neurological Disorders - Drug Targets Methods to Assess Tissue-Specific Distribution and Metabolism of Drugs
Current Drug Metabolism Understanding the Basis for the Association of apoE4 with Alzheimers Disease: Opening the Door for Therapeutic Approaches
Current Alzheimer Research Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) IoT based Low Power Wearable ECG Monitoring System
Current Signal Transduction Therapy Association between HbA1C (Glycated Hemoglobin) and Clinical Outcomes in Patients with Subarachnoid Hemorrhage After Neuro-intervention
Current Neurovascular Research Reserpine Induces Apoptosis and Cell Cycle Arrest in Hormone Independent Prostate Cancer Cells through Mitochondrial Membrane Potential Failure
Anti-Cancer Agents in Medicinal Chemistry Computational Methods for the Identification and Optimisation of High Quality Leads
Combinatorial Chemistry & High Throughput Screening Clinical Pharmacology of Novel Selective COX-2 Inhibitors
Current Pharmaceutical Design The Role of Antithrombotic Therapy in Heart Failure
Current Pharmaceutical Design Carvedilol: Just Another Beta-Blocker or a Powerful Cardioprotector?
Cardiovascular & Hematological Disorders-Drug Targets Current Approaches to Glycoprotein Analysis
Protein & Peptide Letters